Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Liu

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
BMJ Open|July 16, 2020
Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocolKristin Ming, Isha Shrestha, Alexander Vazquez, et al.
The Journal of Infectious Diseases|April 22, 2015
Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence MonitoringMonica Gandhi, David V Glidden, Albert Liu, et al.
AIDS Patient Care and Stds|June 6, 2025
Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San FranciscoErin C Wilson, Janet Myers, Geovanny Muñoz Acosta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 17, 2018
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected IndividualsVasantha Jotwani, Rebecca Scherzer, David V Glidden, et al.
JMIR Research Protocols|January 26, 2019
Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled TrialAlbert Liu, Kenneth Coleman, Kelly Bojan, et al.
JMIR Formative Research|April 21, 2026
Integrating Mobile Text Messaging Pre-Exposure Prophylaxis Navigation Services Into a Home HIV and Sexually Transmitted Infection Self-Testing Program in the United States: Formative Work and Pilot Implementation StudyAlbert Liu, Cat-Dancing Alleyne, Juwann Moss, et al.
Physical Review Letters|February 10, 2025
Valley-Mediated Singlet- and Triplet-Polaron Interactions and Quantum Dynamics in a Doped WSe_{2} MonolayerYue Ni, Di Huang, Danfu Liang, et al.
BMC Public Health|December 9, 2023
A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)Seul Ki Choi, José Bauermeister, Ryan C Tingler, et al.
JACC. Clinical Electrophysiology|January 23, 2026
Focus on the Fascicles: A Collection of Challenging CasesChristopher X Wong, Shohei Kataoka, Nanqing Xiong, et al.
Lancet Regional Health. Americas|February 27, 2023
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083Kate M Mitchell, Marie-Claude Boily, Brett Hanscom, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
BMJ Open|July 16, 2020
Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocolKristin Ming, Isha Shrestha, Alexander Vazquez, et al.
The Journal of Infectious Diseases|April 22, 2015
Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence MonitoringMonica Gandhi, David V Glidden, Albert Liu, et al.
AIDS Patient Care and Stds|June 6, 2025
Implementation Barriers and Facilitators in a Pilot Long-Acting HIV Treatment Intervention for Trans Women Living with HIV in San FranciscoErin C Wilson, Janet Myers, Geovanny Muñoz Acosta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 17, 2018
Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected IndividualsVasantha Jotwani, Rebecca Scherzer, David V Glidden, et al.
JMIR Research Protocols|January 26, 2019
Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled TrialAlbert Liu, Kenneth Coleman, Kelly Bojan, et al.
JMIR Formative Research|April 21, 2026
Integrating Mobile Text Messaging Pre-Exposure Prophylaxis Navigation Services Into a Home HIV and Sexually Transmitted Infection Self-Testing Program in the United States: Formative Work and Pilot Implementation StudyAlbert Liu, Cat-Dancing Alleyne, Juwann Moss, et al.
Physical Review Letters|February 10, 2025
Valley-Mediated Singlet- and Triplet-Polaron Interactions and Quantum Dynamics in a Doped WSe_{2} MonolayerYue Ni, Di Huang, Danfu Liang, et al.
BMC Public Health|December 9, 2023
A latent trajectory analysis of young sexual and gender minorities' adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)Seul Ki Choi, José Bauermeister, Ryan C Tingler, et al.
JACC. Clinical Electrophysiology|January 23, 2026
Focus on the Fascicles: A Collection of Challenging CasesChristopher X Wong, Shohei Kataoka, Nanqing Xiong, et al.
Lancet Regional Health. Americas|February 27, 2023
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083Kate M Mitchell, Marie-Claude Boily, Brett Hanscom, et al.
Pageof 11